Psychological Response and Readiness Associated With OCD of the Knee
Launched by BOSTON CHILDREN'S HOSPITAL · Nov 25, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how having a condition called osteochondritis dissecans (OCD) of the knee affects the emotional well-being of young patients. OCD is a problem where the bone underneath the cartilage in the knee becomes damaged, which can lead to pain and difficulties with movement. The study wants to find out if patients feel stressed or depressed because of their diagnosis and treatment. It will also explore how their feelings change as they go through their treatment and whether they feel ready to return to sports.
To participate in this study, young people aged 11 to 19 who have been diagnosed with knee OCD through X-ray or MRI may be eligible. However, those who have had surgery for this condition before, have already been out of sports for more than six months due to non-surgical treatment, or are not fluent in English cannot participate. If a guardian is not comfortable with their child completing the survey, they can also be excluded. Participants can expect to share their experiences and feelings through surveys during their standard treatment, helping researchers understand the psychological challenges associated with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages 11-19
- • Diagnosis of knee OCD confirmed by X-ray or MRI
- Exclusion Criteria:
- • Had previous surgical treatment for their knee OCD lesion
- • Received knee OCD non-operative treatment on the ipsilateral side for \>6 months and taken out of sports/physical activities
- • Guardian not comfortable with child completing survey
- • Is not fluent in English
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Frisco, Texas, United States
Patients applied
Trial Officials
Matthew D Milewski, MD
Principal Investigator
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials